Prasco begins distribution of doxercalciferol capsules

CINCINNATI — Prasco Laboratories announced on Tuesday that it has started shipping the generic version of Hectorol (doxercalciferol) 0.5-, 1.0- and 2.5-mcg capsules, each in 50-count bottles under the Prasco label.



Prasco entered into a distribution and supply agreement with Genzyme, a Sanofi company, for doxercalciferol capsules, the generic version of Hectorol 0.5-, 1.0- and 2.5-mcg capsules.

 

Hectorol capsules are indicated for the treatment of secondary hyperparathyroidism in patients with Stage 3 or Stage 4 chronic kidney disease not on dialysis, and patients with chronic kidney disease on dialysis.